Effects of Aloe vera (L.) Burm. f. in gingivitis: a review of clinical trials

Background and objectives: Gingivitis is the inflammation of gingiva which, unless treated, will lead to periodontitis in susceptible patients. Aloe vera (L.) Burm. f. (aloe) from the family Asphodelaceae (Liliaceae) is a perennial plant which originates from South Africa. Potentially active compounds of the leaves include vitamins, simple/complex polysaccharides, minerals, organic acids, and phenolic compounds. The aim of this study was to review the literature regarding the efficacy and safety of aloe in patients with gingivitis. Methods: Using the search formula "Gingivitis [title/abstract] AND Aloe vera/ Aloe [all fields]", electronic databases, including PubMed, Scopus, Science direct and Cochrane library were searched for clinical trials on treatments containing aloe for gingivitis and relevant articles with English full-text from 2000 until 2017 were finally included.  Results: Total of 8 clinical trials were finally included in this paper. Various preparations of aloe such as mouth rinse and dentifrice have been investigated in patients with gingivitis. Each study has measured the periodontal health via a specific index including plaque index, gingivitis index, and bleeding index, as well as the microbial count and composition of the oral cavity and biomarkers of inflammation in crevicular fluid and aloe could significantly improve the above mentioned parameters. Conclusion: It was concluded that aloe could improve periodontal health either alone or as an adjunct to scaling and root planning treatments. Some studies also proved its efficacy to be equal to other commercially available products such as chlorhexidine without having their side effects

Critical-sized bone defects regeneration using a bone-inspired 3D bilayer collagen membrane in combination with leukocyte and platelet-rich fibrin membrane (L-PRF): An in vivo study

Objectives: We aim to develop a 3D-bilayer collagen (COL) membrane reinforced with nano beta-tricalcium-phosphate (nβ-TCP) particles and to evaluate its bone regeneration in combination with leukocyte-platelet-rich fibrin (L-PRF) in vivo. Background data: L-PRF has exhibited promising results as a cell carrier in bone regeneration in a number of clinical studies, however there are some studies that did not confirm the positive results of L-PRF application. Methods: Mechanical & physiochemical characteristics of the COL/nβ-TCP membrane (1/2 & 1/4) were tested. Proliferation and osteogenic differentiation of seeded cells on bilayer collagen/nβ-TCP thick membrane was examined. Then, critical-sized calvarial defects in 8 white New Zealand rabbits were filled with either Col, Col/nβ-TCP, Col/nβ-TCP combined with L-PRF membrane, or left empty. New bone formation (NBF) was measured histomorphometrically 4 & 8 weeks postoperatively. Results: Compressive modulus increases while porosity decreases with higher β-TCP concentrations. Mechanical properties improve, with 89 porosity (pore size �100 μm) in the bilayer-collagen/nβ-TCP membrane. The bilayer design also enhances the proliferation and ALP activity. In vivo study shows no significant difference among test groups at 4 weeks, but Col/nβ-TCP + L-PRF demonstrates more NBF compared to others (P < 0.05) after 8 weeks. Conclusion: The bilayer-collagen/nβ-TCP thick membrane shows promising physiochemical in vitro results and significant NBF, as ¾ of the defect is filled with lamellar bone when combined with L-PRF membrane. © 201